References
- Rapoport B., Chazenbalk G. D, Jaume J. C., McLachlan S. M. The thyrotropin receptor: Interaction with thyrotropinautoantibodies. Endocr. Rev. 1998; 19: 673–716
- Shimojo N., Kohno Y., Yamaguchi K., Kikuoka S., Hoshioka A., Niimi H., et al. Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptora class II molecule. Proc. Natl. Acad. Sci. USA 1996; 93: 11074–11079
- Kita M., Ahmad R., Marians R., Graves P., Davies T. F. Thyrotoxic death in mice with Graves' disease. Thyroid 1997; 7: SC#2, abstract
- Germain R. N, Ashwell J. D, Lechler R. L, Margulies D. H, Nickerson K. M, Suzuki G., et al. “Exon-shuffling” maps control of antibody-and T-cell-recognition sites to the NH2-terminal domain of the class II major histocompatibility polypeptide A. Proc. Natl. Acad. Sci. USA 1985; 82: 2940–2944
- Nagayama Y., Kaufman K. D, Seto P., Rapoport B. Molecular cloning, sequencefunctional expression of the cDNA for the human thyrotropin receptor. Biochem. Biophys. Res. Comm. 1989; 165: 1184–1190
- Kakinuma A., Chazenbalk G., Filetti S., McLachlan S. M., Rapoport B. Both the 5′3′ non-coding regions of the thyrotropin receptor messenger RNA influence the level of receptor protein expression in transfected mammalian cells. Endocrinology 1996; 137: 2664–2669
- Magnusson R. P, Chazenbalk G. D, Gestautas J., Seto P., Filetti S., DeGroot L. J., et al. Molecular cloning of the complementary deoxyribonucleic acid for human thyroid peroxidase. Mol. Endocrinol. 1987; 1: 856–861
- Chazenbalk G. D, Portolano S., Russo D., Hutchison J. S, Rapoport B., McLachlan S. M. Human organ-specific autoimmune disease: molecular cloningexpression of an autoantibody gene repertoire for a major autoantigen reveals an antigenic dominant regionrestricted immunoglobulin gene usage in the target organ. J. Clin. Invest. 1993; 92: 62–74
- Nishikawa T., Rapoport B., McLachlan S. M. Exclusion of two major areas on thyroid peroxidase from the immunodominant region containing the conformational epitopes recognized by human autoantibodies. J. Clin. Endocrinol. Metab. 1994; 79: 1648–1654
- Chazenbalk G. D, Kakinuma A., Jaume J. C, McLachlan S. M., Rapoport B. Evidence for negative cooperativity among human thyrotropin receptors overexpressed in mammalian cells. Endocrinology 1996; 137: 4586–4591
- Jaume J. C, Kakinuma A., Chazenbalk G. D, Rapoport B., McLachlan S. M. TSH receptor autoantibodies in serum are present at much lower concentrations than thyroid peroxidase autoantibodies: Analysis by flow cytometry. J. Clin. Endocrinol. Metab. 1997; 82: 500–507
- Yamaguchi K., Shimnjo N., Kikuoka S., Hoshioka A., Hirai A., Tahara K., et al. Genetic control of anti-thyrotropin receptor antibody generation in H-2k mice immunized with thyrotropin receptor-transfected fibro-blasts. J. Clin. Endocrinol. Metab. 1997; 82: 4266–4269
- Kikuoka S., Shimojo N., Yamaguchi K., Watanabe Y., Hoshioka A., Hirai A., et al. The formation of thyrotrophin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain. J. Clin. Endocrinol. Metab. 1998; 139: 1891–1898